FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1835452576> ?p ?o ?g. }

• W1835452576 endingPage "278" @default.
• W1835452576 startingPage "278" @default.
• W1835452576 abstract "Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for a variety of malignant and non-malignant hematological disorders. However, many features of transplantation, including the immunosuppressive drugs administered as pre-transplant conditioning as well as the agents administered post-transplant to prevent graft versus host disease (GvHD), serve to compromise the host immune system leaving patients vulnerable to an array of latent and lytic viruses including cytomegalovirus (CMV), adenovirus (AdV), Epstein-Barr virus (EBV), human herpes virus 6 (HHV6) and BK virus (1-4). Conventional therapy for these infections has relied largely upon the use of small molecule antiviral drugs such as ganciclovir (for CMV and HHV6), cidofovir (for AdV and BK) and foscarnet (for CMV) (5-7). However, prolonged use can lead to toxic side effects such as bone marrow suppression (8) and nephrotoxicity (9), as well as the emergence of drug-resistant mutants (10) (e.g., ganciclovir-resistant CMV). Furthermore, since none of these agents improve endogenous virus-specific T cell (VST) immunity, infections frequently recur upon treatment termination, highlighting the need for novel therapies. This has prompted a number of groups, including our own, to evaluate the therapeutic benefits associated with the adoptive transfer of in vitro expanded VSTs and since the mid-1990s we have undertaken a series of clinical trials using stem cell donor-derived T cell lines targeting one or more of these clinically problematic viruses (11,12). Our recent study (13) reports on our efforts to streamline our VST manufacturing platform, enabling the generation of clinical grade VSTs with specificity for AdV, CMV, EBV, BK virus and HHV6. In this editorial we will briefly describe the innovations that allowed the production of this broad spectrum anti-viral product and discuss the potential for extending this approach beyond the HSCT setting." @default.
• W1835452576 created "2016-06-24" @default.
• W1835452576 creator A5020956671 @default.
• W1835452576 creator A5054883123 @default.
• W1835452576 date "2015-10-01" @default.
• W1835452576 modified "2023-10-16" @default.
• W1835452576 title "Adoptive T cell therapy for the treatment of viral infections." @default.
• W1835452576 cites W1810340630 @default.
• W1835452576 cites W1965594537 @default.
• W1835452576 cites W1965808102 @default.
• W1835452576 cites W1968220194 @default.
• W1835452576 cites W1973683879 @default.
• W1835452576 cites W1974454466 @default.
• W1835452576 cites W1978047780 @default.
• W1835452576 cites W1982041503 @default.
• W1835452576 cites W1983062149 @default.
• W1835452576 cites W1993732758 @default.
• W1835452576 cites W1993975573 @default.
• W1835452576 cites W1994433299 @default.
• W1835452576 cites W1996558200 @default.
• W1835452576 cites W2007092861 @default.
• W1835452576 cites W2009325669 @default.
• W1835452576 cites W2017769703 @default.
• W1835452576 cites W2038091610 @default.
• W1835452576 cites W2038307936 @default.
• W1835452576 cites W2040400654 @default.
• W1835452576 cites W2052205244 @default.
• W1835452576 cites W2057544900 @default.
• W1835452576 cites W2066667144 @default.
• W1835452576 cites W2066857625 @default.
• W1835452576 cites W2066860366 @default.
• W1835452576 cites W2069720281 @default.
• W1835452576 cites W2072068308 @default.
• W1835452576 cites W2085814835 @default.
• W1835452576 cites W2094085828 @default.
• W1835452576 cites W2104342628 @default.
• W1835452576 cites W2134672034 @default.
• W1835452576 cites W2137747960 @default.
• W1835452576 cites W2142261360 @default.
• W1835452576 cites W2147189123 @default.
• W1835452576 cites W2149143895 @default.
• W1835452576 cites W2151758954 @default.
• W1835452576 cites W2153549003 @default.
• W1835452576 cites W2159542119 @default.
• W1835452576 cites W2165859817 @default.
• W1835452576 cites W4211018908 @default.
• W1835452576 cites W4248784570 @default.
• W1835452576 doi "https://doi.org/10.3978/j.issn.2305-5839.2015.10.12" @default.
• W1835452576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4630547" @default.
• W1835452576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26605324" @default.
• W1835452576 hasPublicationYear "2015" @default.
• W1835452576 type Work @default.
• W1835452576 sameAs 1835452576 @default.
• W1835452576 citedByCount "4" @default.
• W1835452576 countsByYear W18354525762016 @default.
• W1835452576 countsByYear W18354525762018 @default.
• W1835452576 countsByYear W18354525762021 @default.
• W1835452576 crossrefType "journal-article" @default.
• W1835452576 hasAuthorship W1835452576A5020956671 @default.
• W1835452576 hasAuthorship W1835452576A5054883123 @default.
• W1835452576 hasConcept C126322002 @default.
• W1835452576 hasConcept C159047783 @default.
• W1835452576 hasConcept C203014093 @default.
• W1835452576 hasConcept C2522874641 @default.
• W1835452576 hasConcept C2776090121 @default.
• W1835452576 hasConcept C2776409557 @default.
• W1835452576 hasConcept C2776724271 @default.
• W1835452576 hasConcept C2776824251 @default.
• W1835452576 hasConcept C2777408962 @default.
• W1835452576 hasConcept C2777732132 @default.
• W1835452576 hasConcept C2777965375 @default.
• W1835452576 hasConcept C2778199330 @default.
• W1835452576 hasConcept C2779820661 @default.
• W1835452576 hasConcept C2780303639 @default.
• W1835452576 hasConcept C2780727368 @default.
• W1835452576 hasConcept C2911091166 @default.
• W1835452576 hasConcept C71924100 @default.
• W1835452576 hasConcept C8891405 @default.
• W1835452576 hasConcept C90375314 @default.
• W1835452576 hasConceptScore W1835452576C126322002 @default.
• W1835452576 hasConceptScore W1835452576C159047783 @default.
• W1835452576 hasConceptScore W1835452576C203014093 @default.
• W1835452576 hasConceptScore W1835452576C2522874641 @default.
• W1835452576 hasConceptScore W1835452576C2776090121 @default.
• W1835452576 hasConceptScore W1835452576C2776409557 @default.
• W1835452576 hasConceptScore W1835452576C2776724271 @default.
• W1835452576 hasConceptScore W1835452576C2776824251 @default.
• W1835452576 hasConceptScore W1835452576C2777408962 @default.
• W1835452576 hasConceptScore W1835452576C2777732132 @default.
• W1835452576 hasConceptScore W1835452576C2777965375 @default.
• W1835452576 hasConceptScore W1835452576C2778199330 @default.
• W1835452576 hasConceptScore W1835452576C2779820661 @default.
• W1835452576 hasConceptScore W1835452576C2780303639 @default.
• W1835452576 hasConceptScore W1835452576C2780727368 @default.
• W1835452576 hasConceptScore W1835452576C2911091166 @default.
• W1835452576 hasConceptScore W1835452576C71924100 @default.
• W1835452576 hasConceptScore W1835452576C8891405 @default.
• W1835452576 hasConceptScore W1835452576C90375314 @default.

• next